Label for first homoeopathic product may be illegal, warns senior scientist

June 10, 2009

The labelling for the first homoeopathic product to get a licence from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) should be illegal, because they breach Unfair Trading regulations, argues a senior scientist today.

In a letter published in this week's BMJ, Professor David Colquhoun from University College London says the MHRA "has made a mockery of its own aims" by allowing Arnica 30C pills to be labelled "a homoeopathic medicinal product used with the homoeopathic tradition for the symptomatic relief of sprains, muscular aches, and bruising or swelling after contusions."

This label should be illegal, he says, because the pills contain no trace of the ingredient on the label, but this deceit has been allowed through a legal loophole for a long time now. He points out that if you sold strawberry jam that contained not a trace of strawberry you'd be in trouble.

But he can see no such loophole that allows manufacturers of Arnica 30C to evade the consumer protection laws which ban "falsely claiming that a product is able to cure illnesses" and which apply to the way that "the average consumer" will interpret the label.

The average consumer is unlikely to know that "used with the homoeopathic tradition" is a form of weasel words that actually means "there isn't a jot of evidence that the medicine works," he writes.

Since there is not the slightest evidence that Arnica 30C pills provide symptomatic relief of sprains, etc, the labelling that the MHRA has approved seems to be illegal, he concludes.

In a second letter, Professor Stephen Evans from the London School of Hygiene and Tropical Medicine believes that the MHRA could have resisted granting a licence because there is "good evidence against any efficacy."

This fiasco, he says, takes us back to the days before drug regulation was introduced, partly to prevent hazards of snake oil-type remedies. And he warns that this product "may have major indirect harms - not only in individual patients who may not get benefit from the other effective remedies but also in a general sense by undermining the rational basis for medicine."

In a final letter, Nicholas Moore, a clinical pharmacologist at the University of Bordeaux, says that "giving homoeopathy credit for any kind of demonstrable efficacy is ludicrous."

But he suggests that homoeopathy might be useful as "a truly inactive placebo" for over-treated illnesses such as the common cold and insomnia. This "will not alter the course of the disease. But the patient will feel better, which is one of the aims of medicine's art, if not its science," he writes.

Source: BMJ-British Medical Journal

Related Stories

Recommended for you

Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say

December 11, 2017
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...

FDA's program to speed up drug approval shaved nearly a year off the process

December 7, 2017
Speeding the pace at which potentially lifesaving drugs are brought to market was a rallying cry for Donald Trump as a candidate, and is a stated priority of his Food and Drug Administration commissioner, Dr. Scott Gottlieb. ...

Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017
The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first ...

Surgery-related opioid doses can drop dramatically without affecting patients' pain

December 6, 2017
Some surgeons might be able to prescribe a third of opioid painkiller pills that they currently give patients, and not affect their level of post-surgery pain control, a new study suggests.

Four-fold jump in deaths in opioid-driven hospitalizations

December 4, 2017
People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by Harvard Medical School and published in the December issue of ...

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Ashy
3 / 5 (2) Jun 10, 2009
Medicals, make the research and you will see real Arnica effect. What? You don't want it? It is clear you are afraid of results. You are know that babys and animals could be treat successfully by homoeopathic products. It's not placebo, isn't it?
Sepp
not rated yet Jun 10, 2009
It should be clear even to the most obtuse medical "authority" that homeopathic remedies do not pretend to contain the actual molecules of the starting substance. They work because they have been homeopathically diluted until there are only traces or not even those of the actual substance. They work on the information principle. But then - information seems to be a scarce thing in mainstream medicine.

If a law was made to allow registration of homeopathic medicinal products, how can it then be illegal to make one? Come on. Pharma isn't the only game in town!
Nan2
not rated yet Jun 11, 2009
Tens, if not hundreds of BILLIONS of dollars are thrown into a black hole of the 'supplemental' health products sold without standards or oversight. Many come from overseas sources using core ingredients which are murky and certainly not standard or vetted. Some of these are nothing more than snake oil, some are actually dangerous.

As people are encouraged to self-diagnose and treat, these products can provide the 'appearance' of improvement on the placebo effect to an individual while either masking or even worsening a serious underlying condition. People seeking to treat themselves for serious conditions often worsen to cause increased costs and a worsened outlook, when early intervention could have produced a far better result for the patient and cheaper expenditures for their care.

The FDA and other oversight agencies have failed their mandates to serve in the public interest. Today they seek more power while their failures remain minimized, their staffing minimized and the invasion of profit interests circumventing research and affecting even research initiatives.

It is a sad state of affairs. Buyer beware in both markets. Someone please tell me why pharmaceuticals cannot be produced with oversight and standards of not only the mfg process but inclusive of core ingredients within our borders.

Public distrust is the result of a badly broken health system. Good job. Profits aren't evil but a 450% profit for a sole source medication in a hospital setting is obscene. That is but one example of tactics which didn't create a competitive free market but bankrupted a captured one.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.